Canada Pension Plan Investment Board’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-86,600
Closed -$2.25M 1376
2025
Q2
$2.25M Buy
+86,600
New +$2.09M ﹤0.01% 852
2025
Q1
Sell
-83,000
Closed -$2.38M 1335
2024
Q4
$2.38M Hold
83,000
﹤0.01% 848
2024
Q3
$3.13M Buy
+83,000
New +$2.91M ﹤0.01% 791

Other funds holding CGON

Canada Pension Plan Investment Board's CGON Position: Q3 2025 in Review

Canada Pension Plan Investment Board sold out of CG Oncology (CGON) in Q3 2025, closing a stake of 86,600 shares — an estimated $2.25M sold.

Canada Pension Plan Investment Board first reported a position in CGON in Q3 2024 and held it in 3 quarters. The position peaked at $3.13M in Q3 2024. 176 funds tracked by Wall St. Rank hold CGON as of Q3 2025.

  • Canada Pension Plan Investment Board reported no remaining CG Oncology position as of Q3 2025 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 86,600 CG Oncology shares in Q3 2025, an estimated $2.25M.
  • Canada Pension Plan Investment Board first reported a position in CG Oncology in Q3 2024 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's CG Oncology position peaked at $3.13M in Q3 2024.
  • 176 funds tracked by Wall St. Rank held CG Oncology as of Q3 2025.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2025, filed 13 Nov 2025.